ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

• Status: Completed
• Trial end date: 2019-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Diabetic and nondiabetic patients will be evaluated if they had a first diagnosis of non-valvular atrial fibrillation and in therapy with non-vitamin K oral anticoagulants and with vitamin K oral anticoagulants.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Pavia
• Treatments: Anticoagulants; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Warfarin

Criteria

Inclusion Criteria:

• non-valvular atrial fibrillation

• nondiabetic patients

• type 1 and 2 diabetic patients

Exclusion Criteria:

• patients with cancer

• patients with chronic inflammation diseases